Similar articles

• [Modulators of multidrug resistance in neoplastic cells].

  Grzelakowska-Sztabert B. Grzelakowska-Sztabert B. Postepy Biochem. 1989;35(4):543-61. Postepy Biochem. 1989. PMID: 2577371 Review. Polish. No abstract available.
• Multidrug resistance in the laboratory and clinic.

  Kane SE, Gottesman MM. Kane SE, et al. Cancer Cells. 1989 Sep;1(1):33-6. Cancer Cells. 1989. PMID: 2701361 Review. No abstract available.
• Anthracyclines.

  Batist G. Batist G. Cancer Chemother Biol Response Modif. 2001;19:47-58. Cancer Chemother Biol Response Modif. 2001. PMID: 11686029 Review. No abstract available.
• [The individualized therapy of tumors].

  Mattern J, Volm M. Mattern J, et al. Dtsch Med Wochenschr. 1992 Oct 30;117(44):1685-9. doi: 10.1055/s-2008-1062499. Dtsch Med Wochenschr. 1992. PMID: 1425274 Review. German. No abstract available.
• [Drug treatment principles in malignant tumors of children].

  Gusev LI, Smirtiukov SV, Badolian GKh. Gusev LI, et al. Feldsher Akush. 1983;48(7):34-7. Feldsher Akush. 1983. PMID: 6555092 Russian. No abstract available.